DARIOHEALTH CORP

DRIO stock represents shares of DarioHealth Corp., a digital health company focused on managing chronic conditions. The ticker trades on the Nasdaq Capital Market. DarioHealth offers digital therapeutics and tools for conditions such as diabetes, hypertension, and behavioral health. Investors tracking DRIO are typically interested in the growing digital health sector and the company's efforts to expand its platform and partnerships.

Recent performance for DRIO can be checked using the latest quote and chart on this page, which reflect real-time or delayed market data. Like many small-cap digital health stocks, DRIO may experience notable price swings based on quarterly results, partnership announcements, and broader sector sentiment. For precise recent returns, compare the current price with prior closes and the 52-week range shown in the data panel.

Because DarioHealth may not report consistent positive earnings, traditional valuation metrics like the price-to-earnings ratio may not be meaningful. Investors often look at enterprise value relative to revenue, price-to-sales, cash balances, and progress toward profitability. Comparing these metrics with peers in digital health and monitoring changes over time can provide context. Current valuation ratios for DRIO are available in the financial data section of this page.

To buy DRIO shares, open a brokerage account that offers U.S. stock trading, then search for the ticker DRIO and place a buy order. You can typically choose a market order for immediate execution or a limit order to specify a price. Ensure your account is funded and that you understand any commissions or fees. Fractional shares may be available depending on your broker.

DarioHealth does not currently pay a dividend. The company reinvests capital into growth initiatives, product development, and expanding its digital health platform. As a result, DRIO is generally considered a growth-oriented stock rather than an income stock. Dividend information, if any changes occur, would be announced by the company and reflected in the dividend section of this page.

Key risks for DRIO include its history of losses and need for additional capital, intense competition in digital health, reliance on partnerships and reimbursement, and regulatory changes affecting digital therapeutics. As a small-cap stock, DRIO may also face higher volatility and lower liquidity than larger companies. Investors should review the company's SEC filings for a detailed discussion of risk factors.